Pediatric acute myeloid leukemias treatment: current scientific view

Author:

Makhacheva F. A.1ORCID,Valiev T. T.1ORCID

Affiliation:

1. N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Abstract

The results of treatment of acute myeloid leukemias (AML) in children remain unsatisfactory. Modern therapeutic programs with hematopoietic stem cell transplantation allow us to get 5-year overall survival rate of 65 % in primary patients. For patients with relapses or refractory AML, 5-year overall survival is about 35 %.This article presents the possibilities of chemotherapy and hematopoietic stem cell transplantation in the treatment of AML. The possibilities of epigenetic, immune, and cellular therapy are presented for pediatric AML. Special attention is paid to targeted drugs that only beginning to be used in the complex therapy of AML. 

Publisher

Publishing House ABV Press

Subject

Oncology,Hematology

Reference107 articles.

1. Mentkevich G.L., Mayakova S.A. Leukemia in children. Moscow: Prakticheskaya meditsina, 2009. 253 p. (In Russ.).

2. Becktell K., Houser K., Burke M.J. Epigenetic therapy in a patient with down syndrome and refractory acute myeloid leukemia. J Pediatr Hematol Oncol 2019;41(1):38–40. DOI: 10.1097/MPH.0000000000001158.

3. Aleksandrova G.A., Golubev N.A., Tyurina E.M. et al. Socially significant diseases of the Russian population in 2018 (statistical materials). Ministry of Health of the Russian Federation. Moscow, 2019, 73 p. (In Russ.).

4. Мень Т.Х., Поляков В.Г., Алиев М.Д. Эпидемиология злокачественных новообразований у детей в России. Онкопедиатрия 2014;1(1):7–12.

5. Kelly L.M., Gilliland D.G. Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 2002;3:179–98. DOI: 10.1146/annurev. genom.3.032802.115046.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3